The approach uses syndromic PCR to detect sexually transmitted infections and human papillomavirus simultaneously. Seegene Inc announced a syndromic polymerase chain reaction (PCR)-based testing approach for reproductive tract infections through the simultaneous detection of sexually transmitted infections and human papillomavirus (HPV). The company presented the details and future direction of its testing approach at the Association for Diagnos…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.